Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Genprex, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 28 | 21 | −7 |
| Shares | 670.2K | 1.36M | +686.6K (+102.4%) |
| Value | $152.9K | $229.5K | +$76.6K (+50.1%) |
New holders (1)
Institutions that held Genprex, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 205,180 | $34.8K | 0.00% |
Sold out (8)
Institutions that held Genprex, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 43,103 | $10.0K |
| Two Sigma Securities, LLC | 21,540 | $4.91K |
| Eqis Capital Management, Inc. | 16,580 | $3.78K |
| HighTower Advisors, LLC | 14,000 | $3.19K |
| Mount Yale Investment Advisors, LLC | 50 | $11 |
| FMR LLC | 38 | $9 |
| Curio Wealth, LLC | 10 | $2 |
| Raymond James Financial Inc | 5 | $1 |